早期卡介苗接种、住院与住院死亡:几内亚比绍3项随机试验的次要结局分析
该分析纳入3项随机试验中低出生体重新生儿,比较早期卡介苗接种与不接种对住院风险、病因及严重程度的影响。共6583名婴儿中,卡介苗组与对照组住院率无显著差异,但卡介苗组住院病死率显著降低,主要归因于预防脓毒症致死病例。
要点
- 早期卡介苗接种未改变婴儿住院率,但显著降低住院病死率。
- 住院病死率降低主要来自预防脓毒症致死病例。
- 卡介苗对住院病死率的有益效应完全为非特异性。
核心结论
- 卡介苗接种未影响住院率,但显著降低住院病死率,主要通过预防脓毒症致死病例实现。
- 观察到的卡介苗对住院病死率的有益效应完全为非特异性。
研究设计与样本
- 3项随机试验将低出生体重新生儿随机分配至早期卡介苗接种组或不接种组,住院为次要结局。
- 共纳入6583名婴儿,卡介苗组3297名,对照组3286名。
主要发现
- 共发生908例婴儿住院(卡介苗组450例,对照组458例)和135例住院死亡(卡介苗组56例,对照组79例)。
- 无确诊结核住院病例。
临床怎么用
- 在低出生体重新生儿中,早期卡介苗接种虽不减少住院,但可能降低住院死亡风险,尤其与脓毒症相关死亡。
- 临床决策时应权衡卡介苗的非特异性有益效应与常规接种策略。
局限性
- 住院为次要结局,分析可能受限于统计效能。
- 研究在几内亚比绍开展,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study was performed to examine the effects of early BCG vaccination on the risk, cause, and severity of infant hospitalizations. The analysis included 3 trials randomizing low-weight neonates to early BCG vaccination (intervention) versus no BCG vaccination (usual practice in low-weight neonates, control), with hospitalizations as secondary outcome. METHODS: Hospitalization data were collected at the pediatric ward of the National Hospital. Effects of BCG vaccination on hospitalization risk were assessed in Cox models providing overall and major disease-group incidence rate ratios (IRRs). Severity was assessed by means of in-hospital case-fatality rates and compared by group as cohort study risk ratios (RRs). RESULTS: Among 6583 infants (3297 in BCG group, 3286 controls), there were 908 infant hospitalizations (450 BCG, 458 controls) and 135 in-hospital deaths (56 BCG, 79 controls). The neonatal (28 days), 6-week, and infant (1-year) BCG versus control hospitalization IRRs were 0.97 (95% confidence interval [CI], .72-1.31), 0.95 (.73-1.24), and 0.96 (.84-1.10). Corresponding BCG versus control case-fatality rate RRs were 0.58 (95% CI, .35-.94), 0.56 (.35-.90), and 0.72 (.53-.99). BCG vaccination tended to reduce neonatal and infant sepsis hospitalization rates (IRR, 0.75 [95% CI, .50-1.13] and 0.78 [.55-1.11], respectively), and it reduced the neonatal in-hospital sepsis mortality rate (RR, 0.46; 95% CI, .22-.98). There were no confirmed hospitalizations for tuberculosis. CONCLUSIONS: BCG vaccination did not affect hospitalization rates but reduced in-hospital mortality rates significantly, primarily by preventing fatal cases of sepsis. The observed beneficial effects of BCG on the in-hospital mortality rate were entirely nonspecific. CLINICAL TRIALS REGISTRATION: NCT00146302, NCT00168610, and NCT00625482.
引用
- Schaltz-Buchholzer F, Biering-Sørensen S, Lund N, et al. Early BCG Vaccination, Hospitalizations, and Hospital Deaths: Analysis of a Secondary Outcome in 3 Randomized Trials from Guinea-Bissau. J Infect Dis. 2019. PMID: 30239767. doi:10.1093/infdis/jiy544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。